Michael Barbella, Managing Editor06.27.23
Rockwell Medical Inc. has expanded its geographic footprint by forging a long-term supply agreement with Global Medical Supply Chain LLC to begin selling its hemodialysis concentrates products in the United Arab Emirates.
Rockwell already has an international business and currently sells its hemodialysis concentrates products in various countries throughout North America, South America, Asia, and Africa. Specifically, this includes the Bahamas, Barbados, Belize, Bermuda, Botswana, Colombia, Ecuador, El Salvador, Ethiopia, Ghana, Guatemala, Honduras, Jamaica, Namibia, Nicaragua, Pakistan, Peru, Philippines, Puerto Rico, South Africa, Trinidad and Tobago, U.S. Virgin Islands, United States, Vietnam, and now the United Arab Emirates.
Rockwell's international business accounts for approximately 10% of the company's total revenue. These international partnerships produce favorable economics and diversify the company's revenue base.
"We are currently distributing our hemodialysis concentrates to 25 countries around the globe. Geographic expansion, domestically and internationally, is a major focus for Rockwell as we work to achieve profitability in 2024, generate $100 million in revenue annually in the next few years, and drive towards becoming the leading global supplier of hemodialysis concentrates," Rockwell Medical President/CEO Mark Strobeck, Ph.D., said. "Our products have a positive impact on the lives of hemodialysis patients with end-stage kidney disease. We are proud that our global footprint is growing and that the impact of our hemodialysis portfolio continues to be realized by patients worldwide."
Rockwell Medical Inc. develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. Rockwell Medical provides dialysis clinics and patients with products supported by customer service. Rockwell is focused on long-term growth strategies that enhance its products, its processes, and its people, enabling the company to deliver value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease. Rockwell Medical is the second largest supplier of acid and bicarbonate concentrates for dialysis patients in the United States and has the vision of becoming the leading global supplier of hemodialysis concentrates.
Rockwell already has an international business and currently sells its hemodialysis concentrates products in various countries throughout North America, South America, Asia, and Africa. Specifically, this includes the Bahamas, Barbados, Belize, Bermuda, Botswana, Colombia, Ecuador, El Salvador, Ethiopia, Ghana, Guatemala, Honduras, Jamaica, Namibia, Nicaragua, Pakistan, Peru, Philippines, Puerto Rico, South Africa, Trinidad and Tobago, U.S. Virgin Islands, United States, Vietnam, and now the United Arab Emirates.
Rockwell's international business accounts for approximately 10% of the company's total revenue. These international partnerships produce favorable economics and diversify the company's revenue base.
"We are currently distributing our hemodialysis concentrates to 25 countries around the globe. Geographic expansion, domestically and internationally, is a major focus for Rockwell as we work to achieve profitability in 2024, generate $100 million in revenue annually in the next few years, and drive towards becoming the leading global supplier of hemodialysis concentrates," Rockwell Medical President/CEO Mark Strobeck, Ph.D., said. "Our products have a positive impact on the lives of hemodialysis patients with end-stage kidney disease. We are proud that our global footprint is growing and that the impact of our hemodialysis portfolio continues to be realized by patients worldwide."
Rockwell Medical Inc. develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers worldwide. Rockwell Medical provides dialysis clinics and patients with products supported by customer service. Rockwell is focused on long-term growth strategies that enhance its products, its processes, and its people, enabling the company to deliver value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease. Rockwell Medical is the second largest supplier of acid and bicarbonate concentrates for dialysis patients in the United States and has the vision of becoming the leading global supplier of hemodialysis concentrates.